Xiaofan Jia
Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nutrition Surveys | 23 | 2024 | 266 | 2.410 |
Why?
| | China | 40 | 2024 | 217 | 2.370 |
Why?
| | Diet | 17 | 2024 | 1278 | 1.950 |
Why?
| | Diabetes Mellitus, Type 1 | 9 | 2023 | 3715 | 1.530 |
Why?
| | Cognitive Dysfunction | 3 | 2024 | 383 | 1.250 |
Why?
| | Celiac Disease | 3 | 2023 | 294 | 0.900 |
Why?
| | Zinc Transporter 8 | 2 | 2021 | 87 | 0.900 |
Why?
| | Autoantibodies | 7 | 2023 | 1496 | 0.890 |
Why?
| | Choline | 1 | 2024 | 127 | 0.840 |
Why?
| | Dietary Proteins | 1 | 2024 | 135 | 0.820 |
Why?
| | Energy Intake | 4 | 2024 | 485 | 0.820 |
Why?
| | Cohort Studies | 19 | 2024 | 5742 | 0.740 |
Why?
| | Obesity, Abdominal | 4 | 2024 | 48 | 0.730 |
Why?
| | High-Throughput Screening Assays | 2 | 2020 | 158 | 0.730 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 253 | 0.710 |
Why?
| | Autoimmune Diseases | 2 | 2020 | 460 | 0.610 |
Why?
| | Dyslipidemias | 3 | 2024 | 176 | 0.590 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2018 | 10 | 0.570 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2024 | 2531 | 0.560 |
Why?
| | Antibodies, Viral | 2 | 2023 | 625 | 0.560 |
Why?
| | Middle Aged | 36 | 2024 | 33479 | 0.530 |
Why?
| | Nutritional Status | 5 | 2024 | 350 | 0.520 |
Why?
| | Feeding Behavior | 7 | 2024 | 654 | 0.520 |
Why?
| | Ascorbic Acid | 1 | 2018 | 177 | 0.510 |
Why?
| | Aged | 24 | 2024 | 23961 | 0.490 |
Why?
| | Fruit | 5 | 2021 | 140 | 0.480 |
Why?
| | Adult | 38 | 2024 | 37929 | 0.470 |
Why?
| | Young Adult | 25 | 2024 | 13209 | 0.460 |
Why?
| | Prevalence | 11 | 2024 | 2734 | 0.450 |
Why?
| | Mass Screening | 3 | 2021 | 1287 | 0.450 |
Why?
| | Hyperuricemia | 2 | 2024 | 44 | 0.450 |
Why?
| | Biomarkers | 3 | 2024 | 4149 | 0.440 |
Why?
| | Adolescent | 30 | 2024 | 21513 | 0.430 |
Why?
| | Hypertension | 4 | 2024 | 1295 | 0.430 |
Why?
| | Vegetables | 5 | 2024 | 157 | 0.390 |
Why?
| | Female | 37 | 2024 | 73304 | 0.380 |
Why?
| | Humans | 52 | 2024 | 137585 | 0.380 |
Why?
| | Cholesterol, Dietary | 3 | 2016 | 18 | 0.370 |
Why?
| | Male | 35 | 2024 | 67762 | 0.370 |
Why?
| | Gastrointestinal Microbiome | 3 | 2024 | 697 | 0.350 |
Why?
| | Luminescent Measurements | 2 | 2021 | 76 | 0.350 |
Why?
| | Obesity | 5 | 2024 | 2992 | 0.340 |
Why?
| | Snacks | 2 | 2022 | 19 | 0.330 |
Why?
| | Waist Circumference | 3 | 2024 | 143 | 0.310 |
Why?
| | Risk Factors | 13 | 2024 | 10388 | 0.290 |
Why?
| | Cross-Sectional Studies | 8 | 2024 | 5472 | 0.280 |
Why?
| | Incidence | 3 | 2024 | 2804 | 0.270 |
Why?
| | Prospective Studies | 6 | 2024 | 7604 | 0.260 |
Why?
| | Urbanization | 3 | 2022 | 29 | 0.250 |
Why?
| | Body Mass Index | 7 | 2024 | 2389 | 0.250 |
Why?
| | Eating | 3 | 2024 | 380 | 0.240 |
Why?
| | Glutamate Decarboxylase | 2 | 2022 | 170 | 0.230 |
Why?
| | Mental Status and Dementia Tests | 2 | 2021 | 26 | 0.230 |
Why?
| | Mycobiome | 1 | 2024 | 9 | 0.230 |
Why?
| | Iron, Dietary | 1 | 2024 | 22 | 0.220 |
Why?
| | Selenium | 1 | 2024 | 43 | 0.220 |
Why?
| | Multimorbidity | 1 | 2024 | 47 | 0.220 |
Why?
| | Seroepidemiologic Studies | 2 | 2023 | 165 | 0.220 |
Why?
| | Copper | 1 | 2024 | 104 | 0.220 |
Why?
| | Dietary Carbohydrates | 1 | 2024 | 155 | 0.210 |
Why?
| | Metabolic Diseases | 1 | 2024 | 108 | 0.210 |
Why?
| | Micronutrients | 2 | 2021 | 92 | 0.200 |
Why?
| | Restaurants | 1 | 2022 | 25 | 0.200 |
Why?
| | Dietary Fats | 1 | 2024 | 304 | 0.200 |
Why?
| | Sodium, Dietary | 1 | 2022 | 41 | 0.190 |
Why?
| | Overweight | 2 | 2024 | 558 | 0.190 |
Why?
| | Pediatric Obesity | 2 | 2021 | 601 | 0.190 |
Why?
| | Nutritional Requirements | 2 | 2024 | 78 | 0.190 |
Why?
| | Sex Factors | 3 | 2024 | 2071 | 0.190 |
Why?
| | Osteopontin | 1 | 2022 | 33 | 0.190 |
Why?
| | Stroke | 2 | 2024 | 1120 | 0.190 |
Why?
| | C-Reactive Protein | 1 | 2024 | 410 | 0.190 |
Why?
| | Mental Status Schedule | 1 | 2021 | 33 | 0.180 |
Why?
| | Child Nutrition Disorders | 1 | 2021 | 20 | 0.180 |
Why?
| | Electrochemistry | 1 | 2021 | 78 | 0.180 |
Why?
| | Zinc | 1 | 2024 | 297 | 0.180 |
Why?
| | Child | 10 | 2023 | 21935 | 0.170 |
Why?
| | Electrochemical Techniques | 1 | 2020 | 54 | 0.170 |
Why?
| | Lymphopenia | 1 | 2020 | 62 | 0.160 |
Why?
| | Sensitivity and Specificity | 2 | 2022 | 1946 | 0.160 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 109 | 0.160 |
Why?
| | Rural Population | 4 | 2024 | 563 | 0.160 |
Why?
| | Malnutrition | 1 | 2020 | 83 | 0.160 |
Why?
| | Longitudinal Studies | 6 | 2024 | 2844 | 0.160 |
Why?
| | Logistic Models | 3 | 2021 | 2074 | 0.160 |
Why?
| | Nutrition Policy | 1 | 2019 | 61 | 0.160 |
Why?
| | Diabetes Mellitus | 2 | 2024 | 1040 | 0.150 |
Why?
| | Age Factors | 2 | 2024 | 3295 | 0.150 |
Why?
| | Phosphoproteins | 1 | 2021 | 338 | 0.150 |
Why?
| | Calcium, Dietary | 1 | 2018 | 57 | 0.150 |
Why?
| | Food, Preserved | 1 | 2018 | 2 | 0.140 |
Why?
| | Diet Surveys | 3 | 2024 | 95 | 0.140 |
Why?
| | Autoantigens | 1 | 2021 | 430 | 0.140 |
Why?
| | Vitamin A | 1 | 2018 | 58 | 0.140 |
Why?
| | Nuts | 1 | 2018 | 12 | 0.140 |
Why?
| | Health Status | 1 | 2023 | 792 | 0.140 |
Why?
| | Beverages | 1 | 2018 | 69 | 0.140 |
Why?
| | Nutrition Assessment | 1 | 2018 | 92 | 0.140 |
Why?
| | Urban Population | 3 | 2024 | 479 | 0.140 |
Why?
| | Anthropometry | 1 | 2018 | 213 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.130 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 364 | 0.130 |
Why?
| | Neuropsychological Tests | 1 | 2021 | 1023 | 0.130 |
Why?
| | Socioeconomic Factors | 2 | 2019 | 1289 | 0.130 |
Why?
| | Case-Control Studies | 2 | 2022 | 3556 | 0.130 |
Why?
| | Cognition | 2 | 2022 | 1153 | 0.130 |
Why?
| | Aged, 80 and over | 3 | 2024 | 7635 | 0.130 |
Why?
| | Aerosols | 1 | 2016 | 176 | 0.120 |
Why?
| | Cardiovascular Diseases | 3 | 2024 | 2111 | 0.120 |
Why?
| | Patient Compliance | 1 | 2019 | 581 | 0.120 |
Why?
| | Follow-Up Studies | 2 | 2021 | 5131 | 0.120 |
Why?
| | Genome-Wide Association Study | 1 | 2022 | 1431 | 0.120 |
Why?
| | Proteomics | 1 | 2022 | 1111 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.120 |
Why?
| | Infant | 4 | 2023 | 9465 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.110 |
Why?
| | Colorado | 2 | 2023 | 4565 | 0.110 |
Why?
| | Child, Preschool | 4 | 2023 | 11074 | 0.110 |
Why?
| | Environmental Monitoring | 1 | 2016 | 370 | 0.110 |
Why?
| | Cholesterol, LDL | 1 | 2015 | 365 | 0.100 |
Why?
| | Prognosis | 1 | 2021 | 4030 | 0.100 |
Why?
| | Air Pollution | 1 | 2016 | 316 | 0.100 |
Why?
| | Air Pollutants | 1 | 2016 | 430 | 0.090 |
Why?
| | Stress, Psychological | 1 | 2020 | 1100 | 0.090 |
Why?
| | Depression | 1 | 2021 | 1397 | 0.090 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 5778 | 0.080 |
Why?
| | Hepatitis B | 1 | 2010 | 70 | 0.080 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2022 | 549 | 0.080 |
Why?
| | Liver Failure | 1 | 2010 | 94 | 0.080 |
Why?
| | Chronic Disease | 2 | 2024 | 1793 | 0.070 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2010 | 597 | 0.070 |
Why?
| | Mass Spectrometry | 1 | 2010 | 739 | 0.070 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1266 | 0.060 |
Why?
| | Metabolomics | 1 | 2010 | 678 | 0.060 |
Why?
| | Blood Pressure | 2 | 2023 | 1786 | 0.050 |
Why?
| | Fast Foods | 1 | 2022 | 17 | 0.050 |
Why?
| | Transglutaminases | 1 | 2023 | 156 | 0.050 |
Why?
| | Sodium | 1 | 2022 | 217 | 0.050 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2021 | 17 | 0.040 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.040 |
Why?
| | Asymptomatic Infections | 1 | 2020 | 30 | 0.040 |
Why?
| | Fasting | 1 | 2022 | 281 | 0.040 |
Why?
| | Virus Shedding | 1 | 2020 | 48 | 0.040 |
Why?
| | Zoonoses | 1 | 2020 | 33 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2020 | 148 | 0.040 |
Why?
| | Multilevel Analysis | 1 | 2020 | 31 | 0.040 |
Why?
| | Cities | 1 | 2020 | 133 | 0.040 |
Why?
| | Genome, Viral | 1 | 2020 | 144 | 0.040 |
Why?
| | Farmers | 1 | 2020 | 64 | 0.040 |
Why?
| | Virulence | 1 | 2020 | 267 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2020 | 268 | 0.040 |
Why?
| | Meat Products | 1 | 2018 | 25 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 347 | 0.040 |
Why?
| | Seafood | 1 | 2018 | 28 | 0.040 |
Why?
| | Body Composition | 1 | 2022 | 684 | 0.040 |
Why?
| | Plants, Edible | 1 | 2018 | 7 | 0.040 |
Why?
| | Dairy Products | 1 | 2018 | 36 | 0.040 |
Why?
| | Eggs | 1 | 2018 | 25 | 0.040 |
Why?
| | Recommended Dietary Allowances | 1 | 2018 | 18 | 0.040 |
Why?
| | Carotenoids | 1 | 2018 | 43 | 0.040 |
Why?
| | Adipose Tissue | 1 | 2022 | 635 | 0.040 |
Why?
| | Exercise | 2 | 2020 | 2057 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2019 | 499 | 0.040 |
Why?
| | Cost of Illness | 1 | 2020 | 308 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3284 | 0.030 |
Why?
| | Meat | 1 | 2018 | 94 | 0.030 |
Why?
| | Weight Loss | 1 | 2023 | 787 | 0.030 |
Why?
| | Educational Status | 1 | 2019 | 470 | 0.030 |
Why?
| | Population Surveillance | 1 | 2020 | 482 | 0.030 |
Why?
| | Autoimmunity | 1 | 2023 | 908 | 0.030 |
Why?
| | Beijing | 1 | 2016 | 2 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2020 | 513 | 0.030 |
Why?
| | Environmental Pollution | 1 | 2016 | 20 | 0.030 |
Why?
| | Sulfates | 1 | 2016 | 50 | 0.030 |
Why?
| | Animals | 4 | 2022 | 36940 | 0.030 |
Why?
| | Disease Management | 1 | 2020 | 628 | 0.030 |
Why?
| | Nitrates | 1 | 2016 | 92 | 0.030 |
Why?
| | Phylogeny | 1 | 2020 | 904 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2020 | 493 | 0.030 |
Why?
| | Health Surveys | 1 | 2018 | 514 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2020 | 778 | 0.030 |
Why?
| | Carbon | 1 | 2016 | 216 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 622 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2021 | 803 | 0.030 |
Why?
| | Genetic Variation | 1 | 2020 | 991 | 0.030 |
Why?
| | Hypercholesterolemia | 1 | 2015 | 106 | 0.030 |
Why?
| | Particulate Matter | 1 | 2016 | 315 | 0.030 |
Why?
| | Seasons | 1 | 2016 | 547 | 0.030 |
Why?
| | Critical Illness | 1 | 2020 | 811 | 0.030 |
Why?
| | Water | 1 | 2016 | 460 | 0.030 |
Why?
| | Inflammation | 1 | 2024 | 2837 | 0.030 |
Why?
| | Regression Analysis | 1 | 2015 | 1024 | 0.020 |
Why?
| | Phenotype | 1 | 2021 | 3196 | 0.020 |
Why?
| | Disease Progression | 1 | 2020 | 2757 | 0.020 |
Why?
| | Blood Glucose | 1 | 2022 | 2186 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1996 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1639 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3457 | 0.020 |
Why?
| | Glycerylphosphorylcholine | 1 | 2010 | 6 | 0.020 |
Why?
| | Brain | 1 | 2022 | 2668 | 0.020 |
Why?
| | Hospitalization | 1 | 2020 | 2199 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2010 | 195 | 0.020 |
Why?
| | Aging | 1 | 2020 | 1864 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2010 | 147 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 6828 | 0.020 |
Why?
| | United States | 1 | 2023 | 14841 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 10811 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2010 | 2486 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2020 | 15657 | 0.010 |
Why?
| | Rats | 1 | 2010 | 5647 | 0.010 |
Why?
|
|
Jia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|